Hsp90 webinars

Webinar series is currently suspended

Upcoming webinars 2024

June 17, 2024 Webinar cancelled

(to be rescheduled)

Paul Workman (Centre for Cancer Drug Discovery, The Institute of Cancer Research, London, UK)

Discovery and clinical development of NXP800: A clinical stage GCN2/Integrated Stress Response activator that inhibits HSF1-mediated transcription for the treatment of ARID1A mutant ovarian cancer